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Patient perspectives on how to optimise benefits from a
breathlessness service for people with COPD
Tim Luckett1✉, Mary M. Roberts2,3,4, Tracy Smith2,4, Vinita Swami2, Jin-Gun Cho2,3,4 and John R. Wheatley2,3,4
This study aimed to inform understanding of how to optimise patient-perceived benefits from a breathlessness service designed for
patients with moderate to very severe chronic obstructive pulmonary disease (COPD). The Westmead Breathlessness Service (WBS)
trains patients to self-manage over an 8-week programme, with multidisciplinary input and home visits. A qualitative approach was
taken, using semi-structured telephone interviews. Each transcript was globally rated as suggesting ‘significant’, ‘some’ or ‘no’
impact from WBS, and thematic analysis used an integrative approach. Forty-one consecutive participants were interviewed to
reach ‘information power’. Eighteen (44%) participants reported ‘significant’ impact, 17 (41%) ‘some’ impact, and two (5%) ‘no’
impact. Improvements to breathlessness were usually in the affective and impact dimensions but, more uncommonly, also sensory-
perceptual. Participants who benefited in self-esteem, confidence and motivation attributed this to one-to-one multidisciplinary
coaching and home visits. Further research should test whether including/excluding more intensive programme elements based on
individual need might improve cost-effectiveness.
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INTRODUCTION
Chronic breathlessness is a common and debilitating symptom
across many life-limiting conditions, including respiratory disease
(e.g. chronic obstructive pulmonary disease (COPD)), heart disease
and cancer, and often persists despite optimised, guideline
concordant pharmacological treatment of the underlying medical
condition(s)1. Chronic breathlessness includes at least three
dimensions: ‘sensory-perceptual’ (severity and quality), ‘affective’
(unpleasantness and distress) and ‘impact’ (effects on everyday
life)2. Over and above chronic breathlessness on a daily basis,
many people experience episodes of acute-on-chronic breath-
lessness3. These episodes are associated with high levels of
anxiety/panic and often precipitate Emergency Department (ED)
presentations, many of which are not clinically indicated and
represent poor utilisation of healthcare resources4,5.
While chronic breathlessness cannot be cured, it can be
managed with non-pharmacological and pharmacological thera-
pies aimed at modulating the perception of breathlessness and
the individual’s response6. These therapies are ideally delivered
within a self-management framework in which people learn skills
to reduce the impact on functioning and sustain emotional
wellbeing 7,8.
Randomised controlled trials (RCTs) from the UK have tested the
effectiveness of five ‘breathlessness services’ in which expert
multidisciplinary teams train patients to self-manage their chronic
breathlessness using pharmacological and non-pharmacological
therapies. These interventions have varied in duration and
number/disciplines of healthcare professionals involved. Three
services focused on people with lung cancer9–11, while another
three included people with advanced cancer of any tumour type
and/or non-malignant respiratory disease12–14. All except one trial
have demonstrated efficacy for improving breathlessness-related
outcomes9–12; Farquhar et al.13,14 found the Cambridge Breath-
lessness Intervention Service (CBIS) reduced distress due to
breathlessness for patients with advanced cancer but not non-
malignant respiratory disease13,14. However, a qualitative sub-
study of the CBIS found that most patients with non-malignant
respiratory disease perceived at least some benefit, including a
reduction in anxiety/panic and increased confidence in managing
their breathlessness14.
A review by Bausewein et al.15 compared and contrasted
characteristics of the above five services together with their own
untested Munich Breathlessness Service, and identified variability
with regard to: intensity and duration (1–8 sessions over
1–12 weeks); location and mode (face-to-face in the clinic, at
home and/or via telephone); individual versus group delivery; and
the disciplines and specialties involved (especially the degree to
which physicians were involved and a respiratory or palliative
care perspective was emphasised)15. Thus far, there has been only
one attempt to explore the influence of these variables on service
efficacy. Johnson et al. found one session delivered by a single
nurse or allied health professional was as effective as three
sessions for reducing worst breathlessness over the past 24 h in
patients with lung cancer, questioning whether more resource-
intensive services are cost-effective11.
The current article reports on a new Australian breathlessness
service developed specifically for people with moderate to very
severe COPD (defined as FEV1/FVC ≤ 70%; FEV1 ≤ 60% predicted)
and run over 8 weekly sessions (plus pre and post assessments)
through a respiratory medicine outpatient service at a metropo-
litan hospital, which provides tertiary and quaternary services to a
socio-economically and culturally diverse population. Of the
breathlessness services reported to date9–14, the Westmead
Breathlessness Service (WBS) is among the more resource
intensive. The WBS programme is highly multidisciplinary by
including a physician (0.2 full-time equivalent; FTE), two nurses
(total 0.4 FTE), physiotherapist (0.3 FTE), occupational therapist (0.3
FTE) and dietitian (0.2 FTE), and offers in-home as well as
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outpatient individualised sessions. Supplementary Table 1 con-
tains a week-by-week breakdown of WBS programme content.
Referrers to WBS are asked to encourage patients to complete
pulmonary rehabilitation (where feasible) prior to enrolment,
presenting an opportunity to assess the degree to which patients
perceive that the breathlessness service adds value to an
established group intervention with high-level evidence for
efficacy16.
Recruitment for a RCT evaluating WBS is currently underway,
with the primary endpoint being mastery of breathlessness as
measured by the Chronic Respiratory Questionnaire17. The current
article reports on results from a qualitative sub-study of the trial,
which aimed to develop an in-depth understanding of patient
perceptions regarding the nature of any benefits derived from the
service and components deemed most useful. To build on
evidence to date, we were interested to replicate and extend
findings from the qualitative study of CBIS13,14 by further
exploring factors associated with perceived benefit, WBS’s
perceived additional value compared to pulmonary rehabilitation,
the degree to which patients perceived benefits to be associated
with multidisciplinary care and home visits, and perceptions
regarding the frequency and duration of sessions. We were also
interested to learn from patients about ways in which they
perceived the service might be improved, including the views of
patients who derived limited benefit.
RESULTS
Information power was deemed to have been reached after
interviews with 41 participants.
Two patients who completed the WBS programme were
unintentionally omitted from the sample due to a miscommunica-
tion between clinical staff and the researcher conducting the
interviews.
Participants had a mean age of 70.2 years (standard deviation
7.1) and were predominantly men (n= 24, 59%). See Table 1 for
other participant characteristics and Supplementary Table 2 for
illustrative quotes for each section below. Interviews ranged from
10.3 to 29.5 min.
Patient perceptions of overall benefit from WBS
Overall, 37 of the 41 participant transcripts were rated for overall
benefit, with results presented in Table 2. Four of the transcripts
were considered difficult to code with confidence, either because
they contradicted themselves regarding improvements (n= 3) or
had provided insufficient information to rate (n= 1).
Most (n= 13/18) participants who were classified as deriving
significant benefit (Level 1) cited improvements in activities of
everyday living (ADLs) (e.g. housework, shopping), either in terms
of being able to do new activities or perform tasks for a longer
duration or with enhanced capability. For a third of participants
with significant benefit, this flowed on from a perceived reduction
in the severity of their breathlessness. For the remainder, benefit
was characterised as a reduction in the impact and affective
domains of breathlessness described in terms of greater exercise
tolerance, faster recovery, less fear, and increased confidence and
ability to cope.
Other reasons that participants were classified as deriving
significant impact were related either to reports that they had
successfully avoided unnecessary ED presentations or hospitalisa-
tions as a result of strategies they had learned through WBS, or
had significant improvements in emotional wellbeing. The latter
seemed to stem from a greater understanding and acceptance of
COPD, as well as a sense of being cared for and feeling less alone.
Participants were usually classified as receiving some (Level 2)
impact because they described benefit in terms of increased
comfort in, rather than capacity for, ADLs.
The four participants rated as perceiving no (Level 3, n= 3) or
inconsistent (difficult to code, n= 1) benefit, nonetheless praised
the caring attitudes of WBS team members and struggled to
identify ways that the service could be improved.
Extension of themes from the CBIS evaluation
All benefits identified within the CBIS qualitative analysis13,14 were
corroborated by at least some participants within the WBS sample,
although there were a small number of negative cases for each
(i.e. participants whose perspectives differed from the majority).
While all the non-pharmacological therapies were beneficial for
some participants, the proportion who reported benefit from each
varied. A majority of participants who reported global benefit
credited at least some role to learning about breathing techniques
(n= 30/35) and the hand-held fan (n= 25/35). A smaller majority
reported benefiting from learning about pacing (n= 19/35), and a
minority from relaxation techniques (n= 10/35). Breathing tech-
niques and the hand-held fan were perceived to provide
psychological benefits as well as to positively influence
breathlessness.
Exercise was perceived as yielding benefits indirectly rather
than directly, by preventing deconditioning. The indirect nature of
benefit and physical challenge associated with exercise made
adherence difficult for many participants, with goal setting and
motivation from the WBS team members often emphasised as
important in enabling this.
Table 1. Characteristics of participants interviewed about their
experiences of the Westmead Breathlessness Service (n= 41).
Characteristic (summary measure)
Age (years) 70.2 (7.1)
Male (%) 59
Lives alone (%) 39
LTOT (%) 12
Completed PR within past year (%) 34
FEV1 (L) 0.79 (0.29)
FEV1 (% predicted) 31 (11)
VC (L) 2.27 (0.76)
VC (% predicted) 66 (15)
FEV1/VC (%) 36 (11)
6MWD (m) 296 (102)
mMRC (a.u.) 3.41 (0.87)
0–10 NRS on exertion (a.u.) 7.8 (1.8)
Data are expressed as mean (standard deviation) unless otherwise stated.
LTOT long term oxygen therapy, PR pulmonary rehabilitation, FEV1 forced
expiratory volume in one second, L litres, VC vital capacity, 6MWD 6min
walk distance, m metres, mMRC modified Medical Research Council
Dyspnoea Scale, NRS numerical rating scale, a.u. arbitrary units.
Table 2. Participant ratings of various levels of benefit after
completing the 8-week Westmead Breathlessness Service programme
(n= 41).
Level of benefit Number (%)
Significant impact (Level 1)—clearly stated WBS made a
difference
18 (44)
Some impact (Level 2)—no major change noted but
valued specific aspects
17 (41)
No impact (Level 3) 2 (5)
Difficult to code 4 (10)
T Luckett et al.
2













As with the CBIS data, there was a substantial emphasis placed
on how the service was delivered as well as its contents, especially
the supportive ‘can do’ attitude of the WBS team.
Patient perceptions of WBS versus pulmonary rehabilitation
Most (n= 26/34) participants who had previously undertaken
pulmonary rehabilitation reported that the WBS programme was
different. Compared with pulmonary rehabilitation, the WBS
programme was perceived to cover a greater variety of therapies
in more depth, be more personalised, involve caregivers more, and
go beyond the physical aspects of COPD to more holistically
address wellbeing and consider comorbidities such as anxiety.
Of four participants who perceived that WBS did not teach new
skills over and above pulmonary rehabilitation, one was among
those who perceived no benefit globally, and a second attributed
WBS with helping to reinforce messages and motivate adherence
to exercise.
Patient perceptions regarding home visits
A key feature of the WBS programme that separated it from
pulmonary rehabilitation for many participants was the availability
of home visits. Around half (n= 20) of the participants perceived
home visits to be an important feature of the service both for
improving access and enabling tearm members to assess and
remediate ADLs in situ. Two participants asserted that they could
not have attended the service if it had been run exclusively at the
hospital due to logistic problems with transport, limitations in
mobility/physical functioning, or anxiety related to travel or
hospitals. However, there were two exceptions, who reported
feeling overwhelmed by the number and frequency of home visits.
Patient perceptions of WBS’s individual focus
Participants often cited the individualised nature of the WBS
programme as beneficial for enabling the WBS team to develop a
deep understanding of their individual needs required to tailor advice,
and to build personal relationships that communicated care and
support and encouraged disclosure. Experience of being cared for and
supported as an individual was among the most commonly
emphasised feature of the service and perceived by many to be
therapeutic in its own right. The characteristics of care and support
that were most commonly accentuated included genuineness, lack of
time constraint, shared understanding about the impacts of breath-
lessness, respect and dignity, and lack of judgement regarding
smoking history. In some cases, this was contrasted with a lesser sense
of support they had experienced in other healthcare encounters.
While two participants reported benefitting from socialising
with other participants in previous group programmes such as
pulmonary rehabilitation, all who were asked considered the
benefits of one-to-one time to outweigh this.
Patient perceptions regarding WBS’s programme duration
Everyone who was asked expressed approval regarding the duration
of the programme, except for two participants who would have
preferred a longer duration and three who perceived the content to
be unnecessarily repetitive and/or include content not relevant to
them. This last group differed from other participants who perceived
repetition of content to be useful for consolidation and reinforce-
ment. Many (n= 17) participants stressed the importance of
knowing that the WBS team was available by telephone after the
sessions were completed to give them a sense of continuing
support and safety in the event of future problems.
Patient perceptions of WBS multidisciplinary input
Participants varied in the degree to which they distinguished the
roles and contributions of different disciplines within the WBS
team. Some participants perceived that team members’ different
skillsets worked in harmony together by focusing on different
aspects of care and reinforcing key messages.
Even where participants seemed less clear on the role of each
discipline, collective attention from a number of health profes-
sionals increased their sense of being cared for and motivated
them to make more effort to self-manage. In this way, participants
drew an explicit causal pathway from the team’s caring and
supportive approach through to their capacity to self-manage and
the resulting impacts on breathlessness.
Changes in participant self-esteem, confidence and motivation
seemed not to be limited to breathlessness self-management but
impacted their lives more generally.
While all the disciplines were singled out for praise, participants
seemed especially impressed with the time commitment and level
of care shown by the doctor.
Participants also highlighted the unique role the doctor played in
prescribing medications (including low-dose opioids), ordering and
interpreting tests, and using medical authority to enable access to
healthcare for comorbid conditions and disability benefits.
Although not explicit, there was a sense that the doctor’s
opinion carried special weight, especially on sensitive matters such
as the need for referral to a psychologist or advance care planning.
There were also three negative cases who seemed not to
perceive substantial differences in the roles of WBS team
members. For the participant with no global benefit, this extended
even to the doctor’s role.
Patients’ suggestions for improving WBS
When asked how to improve WBS, more than half (n= 25) of
participants responded by saying this would be difficult to do
because quality was already so high. Everyone who volunteered
improvements (n= 16) cited problems with travelling to/from the
hospital due to a lack of means of transport or difficulty parking.
While home visits were perceived to partially offset these
problems, hospital visits were still required for initial assessment
and one follow-up. At least one participant was unaware of the
free patient transport service available to/from the hospital.
A small number of participants also recommended that WBS be
made more widely available, either by including people with
earlier stage disease (n= 1) or by better promoting it to those who
were currently eligible but may not have heard of it (n= 2). Two
participants suggested running WBS as an inpatient service during
the time that patients were admitted for an exacerbation.
Participants asking for the service to be extended in these ways
usually qualified their suggestions by acknowledging that
resources might be too limited to accommodate.
DISCUSSION
This study extends previous qualitative research on the nature of
benefits that patients perceive from attending breathlessness
services13,14, focusing for the first time on a service designed
exclusively for patients with COPD. Patients perceived benefits
across the affective, impact and (less commonly) sensory-
perceptual dimensions of breathlessness, with some patients
reporting benefits to extend to other facets of wellbeing more
generally. Participants generally found it difficult to identify
opportunities for improving the service, citing a high level of
satisfaction. However, some participants perceived there to be
opportunities to improve access to WBS by increasing awareness
of the programme and alleviating transport/parking issues.
Participants generally perceived benefits to be associated with
WBS’s multi-week duration, multidisciplinary input (including
medical) and individualised administration via home visits, and
also reported that the service added substantial value following
pulmonary rehabilitation. Patients’ emphasis on the importance of
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home visits was especially noteworthy given that WBS is a
metropolitan service, suggesting that, even with a relatively short
distance to travel, many patients with COPD struggle to attend
hospital appointments. Our research suggests that even some
metropolitan patients might benefit from telehealth, which is
currently funded by the Australian healthcare system only for
regional and rural areas.
The proportion of participants reporting benefit from WBS was
similar to those reported for the 2-week CBIS and 6-week King’s
College Breathlessness Support Service (BSS). Compared with
CBIS13,14, we found a smaller proportion of WBS participants to
derive either ‘no’ (Level 3) benefit (5% WBS versus 8% CBIS) or
‘significant’ (Level 1) benefit (44% WBS versus 56% CBIS), with a
greater proportion deriving ‘some’ (Level 2) benefit (41% WBS
versus 36% CBIS), as well as some (10%) whose data were difficult
to code. Farquhar et al. gave little information on how they
applied this scale, raising the possibility that our teams used
different criteria. However, leaving aside the distinction between
‘significant’ and ‘some’ benefit, the proportions reporting benefit
of either level from CBIS and WBS are similar, and also
approximate to the 84% (95% confidence interval: 69–98%) of
survey respondents with mixed malignant and non-malignant
conditions who reported benefit from the BSS18. Taken together,
these studies suggest that 80–90% of patients attending breath-
lessness services may derive benefit of some kind. At the same
time, however, this may leave 10–20% of patients who perceive
limited benefit but complete the whole programme, potentially
wasting resources. It may be possible to improve efficiency
through better screening at enrolment and reassessment part-way
through to identify patients who are not responding. Our findings
broadly agree with quantitative analyses suggesting that patients
may be more likely to benefit where they demonstrate needs at
enrolment for improving their confidence in managing breath-
lessness mastery and reducing distress19. However, the range of
variables involved may make it difficult for formal assessments to
improve on a clinical interview of the kind undertaken by the WBS
team currently. Also, from an evaluation perspective, the resulting
incremental increases in the proportion of patients who benefit
are likely to be too small to be reliably detected in RCTs.
Results from qualitative studies to date also raise the question
of how future trials of breathlessness services should measure
benefits, given how wide-ranging and difficult to quantify these
are even when informed by in-depth data. To date, standardised
patient-reported outcomes (PROs) have been the most common
endpoints in breathlessness service trials15. However, these are
necessarily limited in their capacity to assess benefit across diverse
domains without over-burdening patients with multiple surveys.
PROs also typically fail to account for variations in the relative
value accorded different domains by different patients. While it
may be tempting to use a measure of overall quality of life to
address these issues, such measures typically have limited
responsiveness to disease-specific interventions20. To inform
future outcome measurement, trialists are encouraged to include
further qualitative sub-studies to provide an ever more nuanced
understanding of the breadth and depth of benefits21.
Patient feedback on WBS, CBIS and BSS has consistently
emphasised the importance, not only of educational content,
but its delivery in an individualised way by a caring team13,14,18.
The current study suggests that one-to-one attention of this kind
is not only necessary to understand patient needs and tailor
advice, but may also be therapeutic in its own right. Our findings
are consistent with previous research showing that patients with
COPD may sometimes blame themselves for having caused their
disease by smoking and feel ‘unworthy’ of care, with negative
impacts on self-management and help-seeking22,23. Our results
suggest that, for some patients, individual attention from a
healthcare team may increase self-esteem, confidence and
motivation to engage in self-management as a requisite pathway
for improving breathlessness-related outcomes. Moreover, this
therapeutic effect appears to depend on patients perceiving that
health professionals are genuine, in turn relying on the quality of
interaction and commitment of time. Our results suggest that one-
to-one person-centred attention from a doctor may have unique
capacity in this regard because of experience-based expectations
among many patients that medical consultations tend to be brief
and biomedical rather than personal in focus. This contribution
needs to be considered when interpreting previous research
showing evidence of effect from a single-session breathlessness
service with no medical involvement11.
On a related point, our research highlights how different
patients may have varying preferences and needs for educational
content and the way this is delivered. Where preferences relate to
choice of non-pharmacological strategy or mode of administra-
tion, breathlessness services should try to accommodate these
through tailoring, especially where delivering unwanted content
may result in wasted resources. However, where such preferences
indicate a lack of understanding or psychological problems that
pose a barrier to effective self-management, they may themselves
become a focus for intervention. In particular, our results accord
with research conducted across health conditions which suggests
that patients may vary in the degree to which they engage as
active partners in healthcare, from those who to choose to be as
autonomous as possible to those who defer expertise and
decision-making to health professionals24. The latter pose a
special challenge for breathlessness services whose raison d’être
is to equip patients with the knowledge, confidence and
motivation to become consummate in self-management. Much
attention has been paid in the literature to promoting a transition
for patients who are initially less willing to take an active role in
their healthcare, variously described in terms of self-efficacy25,
activation26 and empowerment27. Strategies aimed at boosting
these requisites have been collectively subsumed under the
umbrella term of ‘coaching’ and have been found effective for
improving not only self-management but also reducing hospital
admissions and even improving health-related quality of life28.
However, few intervention studies have considered between-
patient variability in the need for coaching. Given that coaching is
typically the most resource-intensive element of breathlessness
self-management interventions, further research is needed to
compare approaches that administer education with versus
without coaching based on assessment of patient need at
enrolment. A more targeted approach may have potential to
improve cost-effectiveness for patients who are already self-
efficacious (and may therefore benefit just as much from self-
management interventions that focus on knowledge transfer and
are administered in a low-resource mode (e.g. electronically29)),
while freeing up resources for patients who need more intensive
coaching. Incorporating measures of self-esteem, confidence and
motivation into future trials might also help to quantify the
relative proportions of patients attending breathlessness services
who have these varying needs.
The current study aimed to minimise selection bias by
interviewing consecutive WBS patients and continuing to sample
until no new information emerged. From an ‘information power’
perspective, our aim was fairly narrow (i.e. focused on WBS rather
than experience of breathlessness more generally), our sample
specificity dense (i.e. people with COPD and experience of
attending WBS), and our analysis more deductive than inductive
—all suggesting that a relatively small sample size should be
adequate30. At the same time, the quality of dialogue was variable
given participants’ poor health, and our analysis was strongly
cross-case rather than case focused, making it possible that further
sampling might have included patients presenting divergent
views. Some participants also demonstrated poor memory and
mild confusion, limiting confidence in the degree to which they
were able to attribute benefits to WBS vis-à-vis pulmonary
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rehabilitation and other care received. While patients reported
valuing the non-judgemental approach taken by WBS to smoking,
this may be more reflective of previous poor experiences than be
a benefit of WBS itself.
A further potential limitation concerns the risks of social
desirability bias and confirmation bias. We attempted to reduce
these risks respectively by having an ‘outsider’ with no involve-
ment in delivering the service interview participants and lead the
analysis. Questions about potential benefits gave participants the
explicit option of answering negatively as well as positively (e.g.
‘did the fan help you or not?’), and participants were only rated as
reporting significant global benefit if they could provide concrete
examples of how their life had improved rather than stating
overall benefit in a generalised way.
In conclusion, this study builds on previous research to suggest
that patients with COPD can derive a wide range of benefits from
a breathlessness service, over and above pulmonary rehabilitation,
that may be difficult to capture comprehensively using a
reasonable range of quantitative measures assessing breath-
lessness severity and/or impact. Participants reported improve-
ments on the affective, impact and (less commonly) sensory-
perceptual dimensions of breathlessness. For some participants,
these benefits appeared to stem from increases in self-esteem,
confidence and motivation, which sometimes extended to other
aspects of life and resulted in improved wellbeing more generally.
Benefits to self-esteem, confidence and motivation were explicitly
attributed by participants to WBS’s long duration, home visits and
one-to-one attention from a multidisciplinary team, including a
doctor. Further research is needed to test whether including/
excluding these more resource-intensive elements based on
patient self-esteem, confidence and motivation assessed at
enrolment can improve the cost-effectiveness of breathlessness
services for people with COPD.
METHODS
The subjective, multi-dimensional nature of chronic breathlessness
required a qualitative approach to enquiry with a phenomenological
orientation. Reporting of the study has been guided by the Consolidated
Criteria for Reporting Qualitative Research31. Ethics approval was provided
by the Human Research Ethics Committee at Westmead Hospital, Sydney,
Australia. All participants gave written informed consent to participate.
Sample
We interviewed consecutive patients attending WBS between June 2017
and September 2019.
Patients were referred to WBS by Western Sydney respiratory specialists,
general practitioners, nurses and allied health personnel. While previous
attendance at pulmonary rehabilitation was encouraged, patients who
were unable to attend for various reasons were still eligible for enrolment.
Eligible patients were consenting adults (i.e. ≥18 years) who had
moderate to very severe COPD (FEV1 ≤ 60% predicted; FEV1/FVC ratio
≤70%) and severe breathlessness (Modified Medical Research Council
Dyspnoea Scale32 score ≥2), and were assessed as willing and able to
actively participate in their own care by WBS team.
Data collection
Semi-structured interviews were conducted by telephone upon comple-
tion of the service and 6 months later. This article focuses on data from
initial interviews only. Interviews focused on perceived benefits of the
service, as well as aspects of the service that participants found useful or
thought could be improved. Questions focused especially on participant
perceptions regarding the service’s duration/frequency, home visits and
multidisciplinary delivery, and what (if any) value it added to pulmonary
rehabilitation. See Box 1 for a topic guide. Interviews were conducted by a
male social scientist with experience in qualitative research (TL), who was
employed as a university academic and had no previous or continuing
relationships with participants. We explained to participants that our
research was aimed at improving WBS for future patients. Interviews were
audio-recorded but no field notes were made. Data were transcribed and
managed using NVivo version 11 software (QSR International 2015).
Analysis
We followed methods described by Farquhar et al.13,14 for making global
judgements on the degree to which each participant reported benefit from
the service. Two researchers (TL and MR) independently applied Farquhar
et al.’s 3-point scale of benefit: Level 1—significant impact (clearly stated
WBS made a difference); Level 2—some impact (no major change
recognised, but valued specific aspects of WBS); Level 3—no impact
(WBS made no difference at all). Disagreements were resolved by
discussion. Where consensus could not be reached easily, a conservative
approach was taken whereby participants were rated as receiving the
lower of level of benefit. Where data were considered insufficient or too
internally inconsistent for either researcher to make a global judgement,
participants were excluded from this part of the analysis.
Thematic analysis used an integrative method designed for informing the
development of health service interventions33. This method uses both
inductive and deductive approaches to build on previous research while
remaining open to new insights. The initial coding structure was defined by
themes identified in Farquhar et al.’s13,14 CBIS qualitative sub-study13,14.
Benefits to breathlessness were coded according to the dimensions of
sensory-perceptual, affective and impact2. It was decided that coding of WBS
interviews would benefit from both ‘insider’ and ‘outsider’ perspectives to
reduce confirmation bias whilst also ensuring that interpretations were
informed by a deep understanding of the WBS structure. Analyses were
therefore conducted independently by two researchers who then met to
discuss any disagreements: TL and a female WBS nurse (MR or VS). Emergent
themes were tested for authenticity in subsequent interviews. As interviews
yielded less and less information to further develop themes, line-by-line
coding was considered unnecessary and only content identified as registering
a new theme by the interviewer was subjected to coding by independent
researchers. We followed Malterud et al. in defining our sample size according
to ‘information power’—a concept similar to saturation but less associated
with a specific methodology30. In the current study, we determined
information power to have been reached when no information warranting
addition of new codes was gleaned over five consecutive interviews.
Reporting summary
Further information on research design is available in the Nature Research
Reporting Summary linked to this article.
DATA AVAILABILITY
In order to protect the identity of participants, interview transcripts cannot be made
available.
Box 1. Interview topic guide
(1) What (if anything) did you find helpful about the clinic?*
(2) What (if anything) did the clinic offer that was not helpful to you?
(3) Is there anything you would change about the breathlessness clinic to
make it more helpful?
(4) What advice would you give other people with COPD and breathlessness
about whether to enrol in the clinic and how to get the most out of it?
(5) Do you think the breathlessness clinic would be useful for everyone with
breathlessness or only for some people, and why?
(6) For people who have completed pulmonary rehabilitation: What (if
anything) did you gain from breathlessness clinic over and above your
experience at pulmonary rehabilitation?
(7) How do you feel now that your involvement in the clinic has finished?
*Follow-up prompts to explore any perceived benefit in more depth:
How (if at all) do you think the clinic helped you:
(1) reduce the severity of your breathlessness?
(2) reduce your breathlessness unpleasantness?
(3) feel more in control of your breathlessness?
(4) with your emotional wellbeing and mood?
(5) with your ability to get around the house and out and about?
(6) with your everyday living?
(7) with any other symptoms or problems apart from your breathlessness?
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CODE AVAILABILITY
The complete NVivo 11 coding structure is available on request.
Received: 10 November 2019; Accepted: 12 March 2020;
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